Roche plans $71M R&D program in Singapore

The China Post reports that Roche is scouting locations in Singapore for a base to house a $71 million translational research initiative. Neither Roche nor economic development officials are saying much, but they are reportedly looking around Singapore General Hospital and the eye, heart and cancer centers. Big Pharma has been aggressively expanding R&D work in Asia as they maneuver to take advantage of emerging markets while tapping lower cost research personnel. Story

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.